Issuance of Stock Acquisition Rights to Directors
First written in FY2017-Q2. 11 of 18 entries say "Restated". Latest entry: FY2026.
19 other companies' latest entry also says "Other".
- FY2026Adjustment of stock acquisition rights due to a stock splitAnnual report
「On 1 April 2026, the company carried out a 2-for-1 stock split of its common shares. As a result, the "Class, details and number of shares underlying the stock acquisition rights" and the "Issue price of shares and amount of capital to be incorporated when shares are issued through the exercise of stock acquisition rights" were adjusted.」
For existing stock acquisition rights for directors, the number of underlying shares, issue price and amount of capital to be incorporated were adjusted in connection with the stock split. - FY2024-Q3RestatedAnnual report
「Not applicable.」
The company states that there were no applicable matters during the third quarter accounting period concerning the stock option plan or other stock acquisition rights. - FY2024-Q2RestatedAnnual report
「Not applicable.」
The company states that there were no applicable matters during the second quarter accounting period concerning the stock option plan or other stock acquisition rights. - FY2023Increase in Shares Through Exercise of Stock Acquisition RightsAnnual report
「1 April 2022–31 March 2023 2,000 7,284,400」
During the fiscal year, the number of shares increased by 2,000 through the exercise of stock acquisition rights, bringing total issued shares to 7,284,400. - FY2023-Q3RestatedAnnual report
「Not applicable.」
The company states that there were no applicable matters during the quarter concerning the stock option plan or other stock acquisition rights. - FY2022RestatedAnnual report
「Based on Article 361 of the Companies Act, the remuneration, etc. relating to stock acquisition rights as stock-based compensation-type stock options for directors, as resolved at the annual general meeting of shareholders and the Board of Directors meeting held on 28 June 2016.」
The company continues to disclose the stock-based compensation-type stock option plan for directors and existing stock acquisition rights. - FY2022-Q3RestatedAnnual report
「Not applicable.」
The company states that there were no applicable matters during the quarter concerning the stock option plan or other stock acquisition rights. - FY2022-Q2Increase in Shares Through Exercise of Stock Acquisition RightsAnnual report
「1 July 2021–30 September 2021 4,000 7,282,400 2,442 4,329,644 2,442 214,576 (Note) The increase resulted from the exercise of stock acquisition rights.」
The number of shares increased by 4,000 through the exercise of stock acquisition rights, bringing total issued shares to 7,282,400 and capital to ¥4,329 million. - FY2022-Q1Increase in Shares Through Exercise of Stock Acquisition RightsAnnual report
「The number of shares issued as of the filing date includes 4,000 shares issued through the exercise of stock acquisition rights from 1 July 2021 to 31 July 2021.」
The number of issued shares as of the filing date increased by 4,000 through the exercise of stock acquisition rights after the end of the quarter. - FY2021RestatedAnnual report
「Based on Article 361 of the Companies Act, the remuneration, etc. relating to stock acquisition rights as stock-based compensation-type stock options for directors, as resolved at the annual general meeting of shareholders and the Board of Directors meeting held on 28 June 2016.」
The company continues to disclose the stock-based compensation-type stock option plan for directors and existing stock acquisition rights. - FY2021-Q3RestatedAnnual report
「Not applicable.」
The company states that there were no applicable matters during the quarter concerning the stock option plan or other stock acquisition rights. - FY2020RestatedAnnual report
「All increases in the number of issued shares resulted from the exercise of stock acquisition rights.」
During the fiscal year, the number of issued shares increased by 10,000 through the exercise of stock acquisition rights, bringing the number of issued shares at year-end to 7,278,400. - FY2020-Q2Increase in Shares Through Exercise of Stock Acquisition RightsAnnual report
「1 July 2019– 30 September 2019 10,000 7,278,400 5,530 4,327,202 5,530 212,134 (Note) The increase resulted from the exercise of stock acquisition rights.」
The number of shares increased by 10,000 through the exercise of stock acquisition rights from July to September 2019, bringing total issued shares to 7,278,400. - FY2020-Q1Increase in Shares Through Exercise of Stock Acquisition RightsAnnual report
「The number of shares issued as of the filing date includes 10,000 shares issued through the exercise of stock acquisition rights from 1 July 2019 to 31 July 2019.」
The number of issued shares as of the filing date increased by 10,000 shares through the exercise of stock acquisition rights. - FY2019RestatedAnnual report
「Based on Article 361 of the Companies Act, the remuneration, etc. relating to stock acquisition rights as stock-based compensation-type stock options for directors, as resolved at the annual general meeting of shareholders and the Board of Directors meeting held on 28 June 2016.」
The company continues to disclose the stock-based compensation-type stock option plan for directors and existing stock acquisition rights. - FY2018RestatedAnnual report
「Based on Article 361 of the Companies Act, the remuneration, etc. relating to stock acquisition rights as stock-based compensation-type stock options for directors, as resolved at the annual general meeting of shareholders and the Board of Directors meeting held on 28 June 2016.」
The company continues to disclose the stock-based compensation-type stock option plan for directors and existing stock acquisition rights. - FY2017RestatedAnnual report
「⑫ Based on Article 361 of the Companies Act, the remuneration, etc. relating to stock acquisition rights as stock-based compensation-type stock options for directors, as resolved at the annual general meeting of shareholders and the Board of Directors meeting held on 28 June 2016.」
The company continues to issue and grant stock-based compensation-type stock options for directors. For 2016, there were 50 stock acquisition rights covering 50,000 shares. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
The company issued 50 stock acquisition rights for directors, representing 50,000 underlying shares, with an exercise period from 26 June 2017 to 28 June 2036.